The future of population registers: Linking routine health datasets to assess a population's current glycaemic status for quality improvement

BMJ Open

Volumn 4, Issue 4, 2014, Pages

  Chan, Wing Cheuk ^a   Jackson, Gary ^b   Wright, Craig Shawe ^c   Orr Walker, Brandon ^a   Drury, Paul L ^d   Boswell, D Ross ^a   Lee, Mildred Ai Wei ^a   Papa, Dean ^a   Jackson, Rod ^e  

^a Manukau SuperClinic   (New Zealand)

^b Health Partners Consulting Group   (New Zealand)

^c Sapere Research Group   (New Zealand)

^d GREEN LANE HOSPITAL   (New Zealand)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; DIABETES MELLITUS; DIET RESTRICTION; DYSGLYCEMIA; ETHNICITY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEALTH CARE UTILIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OBSERVATIONAL STUDY; REGISTER; RETROSPECTIVE STUDY; TOTAL QUALITY MANAGEMENT; AGE; ANALYSIS; FORECASTING; MEDICAL RECORD; MIDDLE AGED; NEW ZEALAND; PREVALENCE; PROCEDURES; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; FORECASTING; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; NEW ZEALAND; PREVALENCE; QUALITY IMPROVEMENT; REGISTRIES; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 84899579730     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003975     Document Type: Article

References (40)

1. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011;378:31-40.
2. Tricco AC, Ivers NM, Grimshaw JM, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet 2012;379:2252-61.
3. NHS diabetes. Coding, classification and diagnosis of diabetes. A review of the coding, classification and diagnosis of diabetes in primary care in England with recommendations for improvement. Newcastle: NHS Diabetes, 2011.
4. Okura Y, Urban LH, Mahoney DW, et al. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004;57:1096-103. (Pubitemid 39446649)
5. Morgan CL, Currie CJ, Stott NCH, et al. Estimating the prevalence of diagnosed diabetes in a health district of Wales: the importance of using primary and secondary care sources of ascertainment with adjustment for death and migration. Diabet Med 2000;17:141-45. (Pubitemid 30159050)
6. Wilson SE, Lipscombe LL, Rosella LC, et al. Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: a population-based study. BMC Health Serv Res 2009;9:41.
7. Ministry of Health. National Health Index data dictionary version 5.3. Wellington: Ministry of Health, 2009.
8. Ministry of Health. National Health Index. Secondary National Health Index 2014. http://www.health.govt.nz/our-work/health-identity/national-health- index/national-health-index-overview
9. Ministry of Health. Establishment service specifications for essential primary health care services provided by primary health organisations. Wellington: Ministry of Health, 2002.
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62-9.
11. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO Consultation. Geneva: World Health Organization, 2011.
12. Ministry of Health. Ethnicity data protocols for the health and disability Sector. Wellington: Ministry of Health, 2004.
13. Ahmad OB, Boschi-Pinto C, Lopez AD, et al. Age standardization of rates: a new WHO standard GPE discussion paper Series: No. 31. Geneva: World Health Organization, 2000.
14. Statistics New Zealand. Population projections prepared for Ministry of Health. 2011 edn. Wellington: Statistics New Zealand, 2011.
15. New Zealand Guidelines Group. New Zealand Cardiovascular Guidelines Handbook: a summary resource for primary care practitioners. 2nd edn. Wellington: New Zealand Guidelines Group, 2009.
16. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet 2010;375:408-18.
17. Smith J, Jackson G, Orr-Walker B, et al. A population-based approach to the estimation of diabetes prevalence and health resource utilisation. N Z Med J 2010;123:62-73.
18. Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 2006;144:465-74. (Pubitemid 46780669)
19. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002;288:1775-9.
20. O'Connor PJ, Bodkin NL, Fradkin J, et al. Diabetes performance measures: current status and future directions. Diabetes Care 2011;34:1651-9.
21. Blakely T, Robson B, Atkinson J, et al. Unlocking the numerator-denominator bias. I: Adjustments ratios by ethnicity for 1991-94 mortality data. The New Zealand Census-Mortality Study. N Z Med J 2002;115:39-43. (Pubitemid 34162600)
22. Chan WC, Wright C, Riddell T, et al. Ethnic and socioeconomic disparities in the prevalence of cardiovascular disease in New Zealand. N Z Med J 2008;121:1285.
23. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: World Health Organization, 2006.
24. Gray J, Orr D, Majeed A. Use of Read codes in diabetes management in a south London primary care group: implications for establishing disease registers. BMJ 2003;326:1130.
25. Harvey JN, Craney L, Kelly D. Estimation of the prevalence of diagnosed diabetes from primary care and secondary care source data: comparison of record linkage with capture-recapture analysis. J Epidemiol Community Health 2002;56:18-23. (Pubitemid 34076266)
26. Anwar H, Fischbacher CM, Leese GP, et al. Assessment of the under-reporting of diabetes in hospital admission data: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabet Med 2011;28:1514-19.
27. Mooy J, Grootenhuis P, de Vries H, et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 1996;39:298-305. (Pubitemid 26066801)
28. McKnight JA, Morris AD, Cline D, et al. Implementing a national quality assurance system for diabetes care: the Scottish Diabetes Survey 2001-2006. Diabet Med 2008;25:743-6. (Pubitemid 351782838)
29. NHS Employers, British Medical Association. Quality and outcomes framework for 2012/13. Guidance for PCOs and practices. London: NHS Employers, 2012.
30. Statistics New Zealand. QuickStats about population mobility. Wellington: Statistics New Zealand, 2007.
31. Dennett A, Stillwell J. Population turnover and churn: enhancing understanding of internal migration in Britain through measures of stability. Popul Trends 2008(134):24-41.
32. Bogue DJ. Basics of contemporary U.S. internal mobility and immigration. In: Bogue DJ, Liegel G, Kozloski M. eds. Immigration, internal migration, and local mobility in the US. Northampton, MA, USA: Edward Elgar, 2009:1-30.
33. Ministry of Health. National Health Index questions and answers. Secondary National Health Index questions and answers. http://www.health.govt. nz/our-work/health-identity/national-health-index/nhi-information-health- consumers/national-health-index-questions-and-answers
34. Ministry of Health. National Immunisation Register. Secondary National Immunisation Register, 2014. http://www.health.govt.nz/our-work/preventative- health-wellness/immunisation/national-immunisation-register
35. Jackson R, Lawes CMM, Bennett DA, et al. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005;365:434-1.
36. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-11.
37. Cheng YJ, Gregg EW, Geiss LS, et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. Popul Diab Care 2009;32:2027-32.
38. Tapp RJ, Tikellis G, Wong TY, et al. Longitudinal association of glucose metabolism with retinopathy. Diabetes Care 2008;31:1349-54.
39. Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care 2011;34(Suppl 2):S184-90.
40. New Zealand Society for the Study of Diabetes. NZSSD position statement on the diagnosis of and screening for type 2 Diabetes. Dunedin: New Zealand Society for the Study of Diabetes, 2011.